In situ absorption in rat intestinal tract of solid dispersion of annonaceous acetogenins

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Dang, Yun Jie ^a   Feng, Han Zhou ^a   Zhang, Limei ^a   Hu, Chun Hui ^a   Zhu, Chun Yan ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOGENIN; MACROGOL;

ANNONA SQUAMOSA; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISPERSION; DUODENUM; ILEUM; INTESTINE; JEJUNUM; MALE; NONHUMAN; RAT; SOLUBILITY; STOMACH ABSORPTION;

EID: 84859750468     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/879676     Document Type: Article

References (38)

1. Alali F. Q., Liu X. X., McLaughlin J. L., Annonaceous acetogenins: recent progress Journal of Natural Products 1999 62 3 504 540 (Pubitemid 29165237)
2. Bermejo A., Figadre B., Zafra-Polo M. C., Barrachina I., Estornell E., Cortes D., Acetogenins from annonaceae: recent progress in isolation, synthesis and mechanisms of action Natural Product Reports 2005 22 2 269 303 (Pubitemid 40589049)
3. McLaughlin J. L., Paw paw and cancer: annonaceous acetogenins from discovery to commercial products Journal of Natural Products 2008 71 7 1311 1321
4. Ye Q., He K., Oberlies N. H., Zeng L., Shi G., Evert D., McLaughlin J. L., Longimicins A-D: novel bioactive acetogenins from Asimina longifolia (annonaceae) and structure-activity relationships of asimicin type of annonaceous acetogenins Journal of Medicinal Chemistry 1996 39 9 1790 1796 (Pubitemid 26142821)
5. Oberlies N. H., Chang C. J., McLaughlin J. L., Structure-activity relationships of diverse annonaceous acetogenins against multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells Journal of Medicinal Chemistry 1997 40 13 2102 2106 (Pubitemid 27265985)
6. Yang S., Yu J., Xu L., Chemical constituents of annonaceae plants and their antitumor activities Acta Academiae Medicinae Sinicae 2000 22 4 376 382
7. Tormo J. R., Gallardo T., Aragn R., Cortes D., Estornell E., Specific interactions of monotetrahydrofuranic annonaceous acetogenins as inhibitors of mitochondrial complex I Chemico-Biological Interactions 1999 122 3 171 183 (Pubitemid 29421776)
8. Gallardo T., Saez J., Granados H., Tormo J. R., Velez I. D., Brun N., Torres B., Cortes D., 10-oximeguanacone, the first nitrogenated acetogenin derivative found to be a potent inhibitor of mitochondrial complex I Journal of Natural Products 1998 61 8 1001 1005 (Pubitemid 28417258)
9. Derbré S., Gil S., Taverna M., Boursier C., Nicolas V., Demey-Thomas E., Vinh J., Susin S. A., Hocquemiller R., Poupon E., Highly cytotoxic and neurotoxic acetogenins of the Annonaceae: new putative biological targets of squamocin detected by activity-based protein profiling Bioorganic and Medicinal Chemistry Letters 2008 18 21 5741 5744
10. Cavé A., Figadre B., Laurens A., Cortes D., Acetogenins from Annonaceae Fortschritte der Chemie organischer Naturstoffe 1997 70 81 288
11. Zafra-Polo M. C., Figadre B., Gallardo T., Tormo J. R., Cortes D., Natural acetogenins from annonaceae, synthesis and mechanisms of action Phytochemistry 1998 48 7 1087 1117 (Pubitemid 28317168)
12. Zeng L., Ye Q., Oberlies N. H., Shi G., Gu Z. M., He K., McLaughlin J. L., Recent advances in annonaceous acetogenins Natural Product Reports 1996 13 4 275 306 (Pubitemid 26368721)
13. Kuwabara K., Takada M., Iwata J., Tatsumoto K., Sakamoto K., Iwamura H., Miyoshi H., Design syntheses and mitochondrial complex I inhibitory activity of novel acetogenin mimics European Journal of Biochemistry 2000 267 9 2538 2546 (Pubitemid 30304248)
14. Lannuzel A., Michel P. P., Hglinger G. U., Champy P., Jousset A., Medja F., Lombs A., Darios F., Gleye C., Laurens A., Hocquemiller R., Hirsch E. C., Ruberg M., The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism Neuroscience 2003 121 2 287 296 (Pubitemid 37176917)
15. Escobar-Khondiker M., Hllerhage M., Muriel M. P., Champy P., Bach A., Depienne C., Respondek G., Yamada E. S., Lannuzel A., Yagi T., Hirsch E. C., Oertel W. H., Jacob R., Michel P. P., Ruberg M., Hglinger G. U., Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons Journal of Neuroscience 2007 27 29 7827 7837 (Pubitemid 47093824)
16. Yuan S. S. F., Chang H. L., Chen H. W., Kuo F. C., Liaw C. C., Su J. H., Wu Y. C., Selective cytotoxicity of squamocin on T24 bladder cancer cells at the S-phase via a Bax-, Bad-, and caspase-3-related pathways Life Sciences 2006 78 8 869 874
17. Degli Esposti M., Ghelli A., Ratta M., Cortes D., Estornell E., Natural substances (acetogenins) from the family Annonaceae are powerful inhibitors of mitochondrial NADH dehydrogenase (Complex I) Biochemical Journal 1994 301 1 161 167 (Pubitemid 24214695)
18. Yuan S. S. F., Chang H. L., Chen H. W., Kuo F. C., Liaw C. C., Su J. H., Wu Y. C., Selective cytotoxicity of squamocin on T24 bladder cancer cells at the S-phase via a Bax-, Bad-, and caspase-3-related pathways Life Sciences 2006 78 8 869 874
19. Lu M. C., Yang S. H., Hwang S. L., Lu Y. J., Lin Y. H., Wang S. R., Wu Y. C., Lin S. R., Induction of G2/M phase arrest by squamocin in chronic myeloid leukemia (K562) cells Life Sciences 2006 78 20 2378 2383
20. Liaw C. C., Wu T. Y., Chang F. R., Wu Y. C., Historic perspectives on Annonaceous acetogenins from the chemical bench to preclinical trials Planta Medica 2010 76 13 1390 1404
21. Chiou W. L., Riegelman S., Pharmaceutical applications of solid dispersion systems Journal of Pharmaceutical Sciences 1971 60 9 1281 1302
22. Ford J. L., The current status of solid dispersions Pharmaceutica Acta Helvetiae 1986 61 3 69 88 (Pubitemid 16134014)
23. Leuner C., Dressman J., Improving drug solubility for oral delivery using solid dispersions European Journal of Pharmaceutics and Biopharmaceutics 2000 50 1 47 60 (Pubitemid 30326688)
24. Sekiguchi K., Obi N., Studies on absorption of eutectic mixtures. I. A comparison of the behaviour of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man Chemical Pharmaceutical Bulletin 1961 9 866 872
25. Moneghini M., Kikic I., Voinovich D., Perissutti B., Filipovi-Gri J., Processing of carbamazepinePEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution International Journal of Pharmaceutics 2001 222 1 129 138 (Pubitemid 32525794)
26. Leuner C., Dressman J., Improving drug solubility for oral delivery using solid dispersions European Journal of Pharmaceutics and Biopharmaceutics 2000 50 1 47 60 (Pubitemid 30326688)
27. Okonogi S., Oguchi T., Yonemochi E., Puttipipatkhachorn S., Yamamoto K., Improved dissolution of ofloxacin via solid dispersion International Journal of Pharmaceutics 1997 156 2 175 180 (Pubitemid 27400005)
28. Vasconcelos T., Sarmento B., Costa P., Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discovery Today 2007 12 23-24 1068 1075 (Pubitemid 350186132)
29. Lennerns H., Human intestinal permeability Journal of Pharmaceutical Sciences 1998 87 4 403 410
30. Mori N., Yokooji T., Kamio Y., Murakami T., Characterization of intestinal absorption of mizoribine mediated by concentrative nucleoside transporters in rats European Journal of Pharmacology 2008 586 13 52 58
31. Kim J. S., Mitchell S., Kijek P., Tsume Y., Hilfinger J., Amidon G. L., The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests Molecular Pharmaceutics 2006 3 6 686 694 (Pubitemid 46087485)
32. Li H., Zhao X., Ma Y., Zhai G., Li L., Lou H., Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles Journal of Controlled Release 2009 133 3 238 244
33. Dahan A., Amidon G. L., Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs Molecular Pharmaceutics 2009 6 1 19 28
34. Soria I., Zimmerman C. L., Intestinal absorption of (-)-carbovir in the rat Pharmaceutical Research 1994 11 2 267 271 (Pubitemid 24076222)
35. Eriksson A. H., Varma M. V. S., Perkins E. J., Zimmerman C. L., The intestinal absorption of a prodrug of the mGlu2/3 receptor agonist LY354740 is mediated by PEPT1: in situ rat intestinal perfusion studies Journal of Pharmaceutical Sciences 2010 99 3 1574 1581
36. Streubel A., Siepmann J., Bodmeier R., Drug delivery to the upper small intestine window using gastroretentive technologies Current Opinion in Pharmacology 2006 6 5 501 508 (Pubitemid 44340666)
37. Tanaka N., Imai K., Okimoto K., Ueda S., Tokunaga Y., Ibuki R., Higaki K., Kimura T., Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation Journal of Controlled Release 2006 112 1 51 56
38. Vasconcelos T., Sarmento B., Costa P., Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discovery Today 2007 12 23-24 1068 1075 (Pubitemid 350186132)